首页> 外文期刊>Canadian journal of surgery: Journal canadien de chirurgie >Morbidity resulting from the treatment of tibial nonunion with the Ilizarov frame.
【24h】

Morbidity resulting from the treatment of tibial nonunion with the Ilizarov frame.

机译:Ilizarov框架治疗胫骨骨不连引起的发病率。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine the sources and magnitude of residual morbidity after successful treatment of tibial nonunion using the Ilizarov device and techniques. DESIGN: A retrospective cohort study. SETTING: A level 1 trauma centre. PATIENTS: Sixteen patients with healed tibial nonunion. INTERVENTION: Application of the Ilizarov device and techniques to obtain union of a previous ununited tibial fracture. MAIN OUTCOME MEASURES: Patient satisfaction and sources of morbidity through clinical review and a visual analogue scale. Two disease-specific outcome measurement scales were used to assess ankle dysfunction. Radiographs were examined to determine the presence of arthrosis. RESULTS: Residual pain was present in over 90% of patients at a mean follow-up of 39 months: in 80% the worst pain was in the ankle, less than 10% felt the worst pain in the knee or at the fracture site. Mean ankle osteoarthritis scores were 3.4 for pain and 4.0 for disability, compared with 0.76 and 0.90 respectively for age-matched controls. Mean ankle-hindfoot scores were between 64 and 100. CONCLUSION: Ankle pain with disability is the major source of residual disability after successful use of the Ilizarov device for the treatment of tibial nonunion.
机译:目的:确定使用Ilizarov装置和技术成功治疗胫骨骨不连后残余发病的来源和严重程度。设计:一项回顾性队列研究。地点:一级创伤中心。患者:16例愈合的胫骨骨不连。干预:应用Ilizarov装置和技术获得先前未合并的胫骨骨折的愈合。主要观察指标:通过临床检查和视觉模拟量表,评估患者的满意度和发病率。使用两种疾病特定的结果测量量表来评估踝关节功能障碍。检查X光片以确定是否存在关节病。结果:在平均39个月的平均随访中,超过90%的患者存在残余疼痛:在80%的患者中,最严重的疼痛发生在踝关节,不到10%的患者感到膝盖或骨折部位的最严重疼痛。踝关节骨关节炎的平均疼痛评分为3.4,残疾评分为4.0,而年龄匹配的对照组分别为0.76和0.90。踝后足平均评分在64到100之间。结论:成功使用Ilizarov装置治疗胫骨骨不连后,具有残疾的踝痛是残余残疾的主要来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号